Fund+
Investor profile
Venture capital
Fund+ has backed 2 European tech companies across 2 funding rounds between 2020 and 2026, joining rounds totalling €48M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2020–2026
7 yrs
Total round €
€48M
sum of rounds joined
Deals by year
distinct rounds / yearFund+ — deals by year — interactive chart.
Data table
| Fund+ — deals by year | |
|---|---|
| 2020 | 1 |
| 2026 | 1 |
Top sectors
by dealsFund+ — top sectors — interactive chart.
Data table
| Fund+ — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsFund+ — stages — interactive chart.
Data table
| Fund+ — stages | |
|---|---|
| Debt | 1 |
| Series B | 1 |
Countries
by dealsFund+ — countries — interactive chart.
Data table
| Fund+ — countries | |
|---|---|
| Belgium | 2 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Indigo Diabetes | Belgium | 1 | €38M |
| Novadip Biosciences | Belgium | 1 | €10M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Indigo Diabetes | Series B | €38M | 2020-07 |